Clinical Focus

Previous Articles     Next Articles

Medication in patients with bronchial asthma in Rizhao city

  

  1. Department of Respiratory  Medicine,Tuberculosis Institute of Rizhao, Rizhao 276800, China
  • Online:2017-05-05 Published:2017-05-05
  • Contact: Corresponding author: Feng Liancai, Email: wgflc@163.com

Abstract: ObjectiveTo investigate the medication in patients with bronchial asthma, so as to understand the current status of treatment in bronchial asthma patients in Rizhao city. MethodsA total of 229 patients were selected in a face to face questionnaire survey. The disease identification, history and medication  including the kinds, dosage form and time of medication  were surveyed. ResultsThe percentages of 229 patients with theophylline and shortacting beta2 receptor agonists (included oral and inhale types) were 78.6% and  68.1%, respectively; The percentage with inhaled corticosteroids(ICS)  was  44.5%; The percentage with nonconformal drugs was 36.2%; The average time in patients with oral hormone was longer than that of  ICS(P<0.01); There was statistical significance in age and disease  course  between nonconformal and conformal drugs  (P<0.05).ConclusionIn Rizhao city, the medication in patients with bronchial asthma was not reasonable; the drugs of theophylline and shortacting beta2 receptor agonists in bronchial asthma were prior to the drugs of ICS. There was still  a certain proportion of  patients with oral hormone, but patients with nonconformal drugs were older and their disease courses were longer than those with conformal drugs.

Key words: asthma, theophylline, adrenergic beta2 receptor agonists;glucocorticoids